Nelfinavir: 12 month safety and efficacy versus boosted Indinavir, each in combination with 2 Nucleoside Reverse Transcriptase Inhibitors, in treatment naïve patients.

Abstract

info:eu-repo/semantics/nonPublishe

    Similar works

    Full text

    thumbnail-image

    Available Versions